Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Korro Bio, Inc.Listing on record | BuyD (derivative) | $2.7M | ClusterFirst in 12mo | SEC | |
Korro Bio, Inc.Listing on record | Buy | $2.3M | conv 56ClusterFirst in 12mo | SEC | |
NeueHealth, Inc.Listing unverified | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC |